Yüklüyor......
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
Major depressive disorder (MDD) contributes to a significant worldwide disease burden, expected to be second only to heart disease by 2050. However, accurate diagnosis has been a historical weakness in clinical psychiatry. As a result, there is a demand for diagnostic modalities with greater objecti...
Kaydedildi:
| Yayımlandı: | Front Psychiatry |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4843170/ https://ncbi.nlm.nih.gov/pubmed/27199779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2016.00072 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|